4.3 Article

Resveratrol inhibits nonalcoholic fatty liver disease in rats

Related references

Note: Only part of the references are listed.
Article Chemistry, Multidisciplinary

Resveratrol improves non-alcoholic fatty liver disease by activating AMP-activated protein kinase

Jing Shang et al.

ACTA PHARMACOLOGICA SINICA (2008)

Article Gastroenterology & Hepatology

Beneficial effects versus toxicity of medium-chain triacylglycerols in rats with NASH

Charles S. Lieber et al.

JOURNAL OF HEPATOLOGY (2008)

Article Multidisciplinary Sciences

Sirt1 protects against high-fat diet-induced metabolic damage

Paul T. Pfluger et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)

Article Gastroenterology & Hepatology

Adipokines and cytokines in non-alcoholic fatty liver disease

M. H. Jarrar et al.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2008)

Article Multidisciplinary Sciences

Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes

Jill C. Milne et al.

NATURE (2007)

Article Gastroenterology & Hepatology

Preventive role of genistein in an experimental non-alcoholic steatohepatitis model

Mehmet Yalniz et al.

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2007)

Article Gastroenterology & Hepatology

N-acetylcysteine attenuates oxidative stress and liver pathology in rats with non-alcoholic steatohepatitis

Duangporn Thong-Ngam et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2007)

Article Endocrinology & Metabolism

Infliximab reverses steatosis and improves insulin signal transduction in liver of rats fed a high-fat diet

Raquel Barbuio et al.

JOURNAL OF ENDOCRINOLOGY (2007)

Article Gastroenterology & Hepatology

The expression of SIRT1 in nonalcoholic fatty liver disease induced by high-fat diet in rats

Xiang-Qun Deng et al.

LIVER INTERNATIONAL (2007)

Review Gastroenterology & Hepatology

Obesity, inflammation, and insulin resistance

Steven E. Shoelson et al.

GASTROENTEROLOGY (2007)

Review Gastroenterology & Hepatology

Abnormal lipid and glucose metabolism in obesity: Implications for nonalcoholic fatty liver disease

Samir Parekh et al.

GASTROENTEROLOGY (2007)

Article Gastroenterology & Hepatology

Nonalcoholic fatty liver disease in severely obese subjects

Pierre M. Gholam et al.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2007)

Review Gastroenterology & Hepatology

Polyphenols in the treatment of inflammatory bowel disease and acute pancreatitis

Haim Shapiro et al.

Article Gastroenterology & Hepatology

Insulin resistance accelerates a dietary rat model of nonalcoholic steatohepatitis

Tsuguhito Ota et al.

GASTROENTEROLOGY (2007)

Article Multidisciplinary Sciences

Resveratrol improves health and survival of mice on a high-calorie diet

Joseph A. Baur et al.

NATURE (2006)

Article Gastroenterology & Hepatology

Effect of resveratrol on alcohol-induced mortality and liver lesions in mice

Luis Bujanda et al.

BMC GASTROENTEROLOGY (2006)

Article Gastroenterology & Hepatology

Resveratrol prolongs allograft survival after liver transplantation in rats

Sheng-Li Wu et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2005)

Review Medicine, Research & Experimental

Molecular mediators of hepatic steatosis and liver injury

JD Browning et al.

JOURNAL OF CLINICAL INVESTIGATION (2004)

Article Biochemistry & Molecular Biology

Resveratrol scavenges reactive oxygen species and effects radical-induced cellular responses

SS Leonard et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2003)

Review Gastroenterology & Hepatology

Animal models of steatosis

A Koteish et al.

SEMINARS IN LIVER DISEASE (2001)

Article Medicine, Research & Experimental

NADPH oxidase-derived free radicals are key oxidants in alcohol-induced liver disease

H Kono et al.

JOURNAL OF CLINICAL INVESTIGATION (2000)